BBWI - Bath & Body Works, Inc.
NYSE
->
Consumer Cyclical
->
Specialty Retail
Columbus,
United States
Type: Equity
BBWI price evolution
BBWI
| (in millions $) | 2 Dec 2024 | 3 Sep 2024 | 4 Jun 2024 | 3 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $200 | $146 | $121 | $224 |
| Inventory | $1178 | $863 | $814 | $710 |
| Total current assets | $1720 | $1666 | $1917 | $2115 |
| Long term investments | ||||
| Property, plant & equipment | $2187 | $2209 | $2230 | $2276 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $4984 | $4948 | $5221 | $5463 |
| Current liabilities | ||||
| Accounts payable | $510 | $411 | $403 | $380 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1575 | $1497 | $1221 | $1289 |
| Long term debt | $3883 | $3881 | $4282 | $4388 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $6732 | $6666 | $6898 | $7089 |
| Shareholders' equity | ||||
| Retained earnings | -$1918 | -$1889 | -$1838 | |
| Other shareholder equity | -$1748 | -$1718 | $74 | -$1626 |
| Total shareholder equity | ||||
| (in millions $) | 3 Mar 2024 | 28 Feb 2023 | 1 Mar 2022 | 3 Mar 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3903 | |||
| Short term investments | ||||
| Net receivables | $224 | $226 | $240 | $269 |
| Inventory | $710 | $709 | $709 | $1273 |
| Total current assets | $2115 | $2266 | $3009 | $5579 |
| Long term investments | ||||
| Property, plant & equipment | $2276 | $2243 | $2030 | $2095 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $5992 | |||
| Total investments | ||||
| Total assets | $5463 | $5494 | $6026 | $11571 |
| Current liabilities | ||||
| Accounts payable | $380 | $455 | $435 | $683 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1289 | $1379 | $1290 | $2826 |
| Long term debt | $4388 | $4862 | $4854 | $6366 |
| Total noncurrent liabilities | $9406 | |||
| Total debt | ||||
| Total liabilities | $7089 | $7699 | $7544 | $12232 |
| Shareholders' equity | ||||
| Retained earnings | -$1838 | -$2401 | -$1803 | -$1421 |
| Other shareholder equity | -$1626 | -$2205 | $80 | $84 |
| Total shareholder equity | ||||
| (in millions $) | 2 Dec 2024 | 3 Sep 2024 | 4 Jun 2024 | 3 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1610 | $1526 | $1384 | $2912 |
| Cost of revenue | ||||
| Gross Profit | $700 | $626 | $606 | $1337 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $482 | $443 | $419 | $641 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $39 | $1 | $31 | $44 |
| Interest expense | -$77 | -$77 | -$82 | -$86 |
| Net income | ||||
| Net income | $106 | $152 | $87 | $579 |
| Income (for common shares) | ||||
| (in millions $) | 3 Mar 2024 | 28 Feb 2023 | 1 Mar 2022 | 3 Mar 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7429 | $7560 | $11847 | |
| Cost of revenue | ||||
| Gross Profit | $3236 | $3255 | $4667 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1951 | $1879 | $3087 | |
| Operating income | $1580 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $143 | $251 | $248 | |
| Interest expense | -$345 | -$348 | $438 | |
| Net income | ||||
| Net income | $878 | $800 | $844 | |
| Income (for common shares) | ||||
| (in millions $) | 2 Dec 2024 | 3 Sep 2024 | 4 Jun 2024 | 3 Mar 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$114 | -$40 | -$46 | -$286 |
| Financing activities | ||||
| Dividends paid | -$134 | -$90 | -$45 | -$182 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$710 | -$560 | -$259 | -$815 |
| Effect of exchange rate | -$1 | |||
| Change in cash and equivalents | -$893 | -$570 | -$229 | -$148 |
| (in millions $) | 3 Mar 2024 | 28 Feb 2023 | 1 Mar 2022 | 3 Mar 2021 |
|---|---|---|---|---|
| Net income | $844 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $2039 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$286 | -$328 | -$259 | -$219 |
| Financing activities | ||||
| Dividends paid | -$182 | -$186 | -$120 | -$83 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$815 | -$1562 | -$3188 | $610 |
| Effect of exchange rate | -$1 | -$1 | $1 | $4 |
| Change in cash and equivalents | -$148 | -$747 | -$1954 | $2434 |
News
Fundamentals
| Market cap | $6.58B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 219.11M |
| Revenue | $7.43B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $924.00M |
| Revenue Q/Q | 0.35% |
| Revenue Y/Y | N/A |
| P/E ratio | 7.12 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.88 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $4.22 |
|---|---|
| ROA | 17.93% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.09 |
| Quick ratio | 0.34 |